Conference LibraryGated
Yingzhong Li · Q3 response · Human cytokine validation roadmap
5/16 Antibody Conference Q&A · Q3 (audience question about human-version construct testing). Yingzhong's response acknowledges current data is mouse-cytokine-based · human validation is necessary next step.
- Type
- quote
- Domain
- conference
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- Provenance
- m622_command_round_12_batch_d_2026-05-17
- evidence_grade
- B
- category
- founder_panel_qa
- status
- draft
- instance_tag
- sunvax-antibody-2025
- clinical_claim_softening
- "founder acknowledged human-cytokine data gap · roadmap signal only · not intended to guide individual patient treatment choices"
- quote_text
- Yingzhong response key points (per panel transcript via user m624 canonical): - 目前数据都是 mouse cytokines - 临床前 human 构造体测试是必要下一步 - Human/mouse sequence 差异 → 活性 / 免疫 / 效力可能不同
- panel
- Antibody_Conference_2026_05_15_Q3
- topic
- human_cytokine_validation_roadmap
- significance
- Founder explicitly flagged human-cytokine validation as a roadmap gap · represents a science readiness signal · m623 talking points can use this as an "honest scientist" trust-builder (per yingzhong-l
- speaker_name
- Yingzhong Li
- speaker_affiliation
- SunVax mRNA Therapeutics Inc.
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.